You just read:

Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study

News provided by

Moerae Matrix Inc.

Jul 28, 2015, 08:34 ET